Anti-Myeloperoxidase Antibodies Associate with Future Proliferative Lupus Nephritis
Authors:
Open Access
- 24 December 2017
- journal article
- research article
- Published by Wiley in Autoimmune Diseases
- Vol. 2017, 1-11
Abstract
Background. The subclinical pathophysiology of proliferative lupus nephritis (PLN) has not been fully elucidated. Myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA) is associated with PLN, but prediagnostic levels have not been reported. Methods. We performed a retrospective case-control Department of Defense Serum Repository (DoDSR) study comparing MPO-ANCA levels in longitudinal prediagnostic serum samples for 23 biopsy confirmed proliferative lupus nephritis (PLN) patients to DoDSR identified age, sex, race, and age of serum matched healthy and SLE without LN disease controls. We also compared the temporal relationship of MPO-ANCA to anti-double stranded DNA antibodies (dsDNAab). Results. A greater proportion of PLN patients had prediagnostic MPO-ANCA levels above ≥3 U/mL and ≥6 U/mL compared to SLE without LN (91% versus 43%, ; 57% versus 5%, , resp.). In subgroup analysis, the MPO-ANCA threshold of ≥3 U/mL was significant at <1 year (88% versus 39%, ) and 1–4 years (87% versus 38%, ) prior to diagnosis. Statistically significant subclinical MPO-ANCA levels (≥3 U/mL) occurred prior to statistically significant dsDNAab ≥ 3 IU/ml (89% versus 11%, ). Conclusions. Subclinical MPO-ANCA levels could distinguish future PLN from SLE without LN. MPO-ANCA manifests prior to clinical disease and subclinical dsDNAab to suggest that it may contribute directly to PLN pathogenicity.
Keywords
This publication has 45 references indexed in Scilit:
- Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitisJournal of Clinical Investigation, 2013
- Asymptomatic Autoantibodies Associate with Future Anti-glomerular Basement Membrane DiseaseJournal of the American Society of Nephrology, 2011
- Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus ErythematosusThe Journal of Immunology, 2011
- Diffuse alveolar hemorrhage in lupus nephritis complicated by microscopic polyangiitisClinical and Experimental Nephrology, 2011
- Impairment of neutrophil extracellular trap degradation is associated with lupus nephritisProceedings of the National Academy of Sciences, 2010
- Necrotizing and Crescentic Lupus Nephritis with Antineutrophil Cytoplasmic Antibody SeropositivityClinical Journal of the American Society of Nephrology, 2008
- Novel DNASE I mutations related to systemic lupus erythematosusArthritis & Rheumatism, 2004
- ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUSRheumatology, 1996
- Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD)Digestive Diseases and Sciences, 1994
- Anti-Neutrophil Cytoplasmic Autoantibodies with Specificity for Myeloperoxidase in Patients with Systemic Vasculitis and Idiopathic Necrotizing and Crescentic GlomerulonephritisNew England Journal of Medicine, 1988